Cardiovascular

Hypertension staging and first drugs, lipids by ASCVD risk, heart failure follow-up, atrial fibrillation anticoagulation and the chest-pain decisions of primary care.

Articles

Statin Decisions by ASCVD Risk: Who Gets a Statin, Which Intensity and How to MonitorStatin decisions for the NP exam: 2018 benefit groups and the 2026 PREVENT risk tiers, statin intensity doses,…9 min read

Hypertension on the NP Exam: Staging, When to Start Medication and the First Drug2025 AHA/ACC hypertension for the NP exam: confirm and stage the pressure, apply the PREVENT 7.5 percent rule …10 min read

Heart Failure Follow-Up in Primary Care: GDMT, Weights, Labs and When to ReferHeart failure follow-up for the NP exam: classify by ejection fraction, titrate the four GDMT classes, time th…9 min read

Choosing the First Antihypertensive by Comorbidity: Diabetes, CKD, Heart Failure, Pregnancy and AgeFirst antihypertensive by comorbidity: ACE inhibitor or ARB for albuminuria, GDMT for HFrEF, labetalol or nife…9 min read

Atrial Fibrillation in the Clinic: CHA2DS2-VASc, Anticoagulant Choice and Rate ControlAtrial fibrillation for the NP exam: score CHA2DS2-VASc, start a DOAC at 2 or more in men and 3 or more in wom…9 min read